The Government does recognise that these are substantial powers and they would have a particular impact on the owners of testing laboratories. It's for that reason that the bill provides for compensation or payment for those services should those powers be used. I would note that these powers are not unprecedented—these powers are not unprecedented. There are already provisions in the Health Act of 1956 that make similar kinds of provisions. These ones, however, are tied specifically to our COVID-19 response. They were in a piece of legislation that has to be consistently and regularly renewed by Parliament and that will expire. So by tying them to the COVID-19 response—yes, it is an infringement on the freedom of those businesses, if you like, potentially, but it would be a very high threshold to use that. The reason for it is simply this: if we're dealing with a severe outbreak, testing is critical, and we have to make sure that we can make the best use of all of the testing available in the environment where supplies around testing are very constrained internationally—so our ability to get testing supplies on a large scale into the country continues to be constrained internationally, so we've got to make the best use of the ones that we have available.